Rosanò L - Search Results

1

Therapeutic targeting of the endothelin-A receptor in human ovarian carcinoma: efficacy of cytotoxic agents is markedly enhanced by co-administration with atrasentan.

Rosanò L, Spinella F, Di Castro V, Natali PG, Bagnato A. Rosanò L, et al. J Cardiovasc Pharmacol. 2004 Nov;44 Suppl 1:S132-5. doi: 10.1097/01.fjc.0000166259.96980.6a. J Cardiovasc Pharmacol. 2004. PMID: 15838262

2

Role of endothelin-1 in neovascularization of ovarian carcinoma.

Salani D, Di Castro V, Nicotra MR, Rosanò L, Tecce R, Venuti A, Natali PG, Bagnato A. Salani D, et al. Among authors: rosano l. Am J Pathol. 2000 Nov;157(5):1537-47. doi: 10.1016/S0002-9440(10)64791-8. Am J Pathol. 2000. PMID: 11073813 Free PMC article.

3

Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo.

Salani D, Taraboletti G, Rosanò L, Di Castro V, Borsotti P, Giavazzi R, Bagnato A. Salani D, et al. Among authors: rosano l. Am J Pathol. 2000 Nov;157(5):1703-11. doi: 10.1016/S0002-9440(10)64807-9. Am J Pathol. 2000. PMID: 11073829 Free PMC article.

4

Endothelin receptor blockade inhibits proliferation of Kaposi's sarcoma cells.

Bagnato A, Rosanò L, Di Castro V, Albini A, Salani D, Varmi M, Nicotra MR, Natali PG. Bagnato A, et al. Among authors: rosano l. Am J Pathol. 2001 Mar;158(3):841-7. doi: 10.1016/S0002-9440(10)64032-1. Am J Pathol. 2001. PMID: 11238033 Free PMC article.

5

Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells.

Rosanò L, Varmi M, Salani D, Di Castro V, Spinella F, Natali PG, Bagnato A. Rosanò L, et al. Cancer Res. 2001 Nov 15;61(22):8340-6. Cancer Res. 2001. PMID: 11719468

6

Endothelin-1 protects ovarian carcinoma cells against paclitaxel-induced apoptosis: requirement for Akt activation.

Del Bufalo D, Di Castro V, Biroccio A, Varmi M, Salani D, Rosanò L, Trisciuoglio D, Spinella F, Bagnato A. Del Bufalo D, et al. Among authors: rosano l. Mol Pharmacol. 2002 Mar;61(3):524-32. doi: 10.1124/mol.61.3.524. Mol Pharmacol. 2002. PMID: 11854432

7

Endothelin-1 induces vascular endothelial growth factor by increasing hypoxia-inducible factor-1alpha in ovarian carcinoma cells.

Spinella F, Rosanò L, Di Castro V, Natali PG, Bagnato A. Spinella F, et al. Among authors: rosano l. J Biol Chem. 2002 Aug 2;277(31):27850-5. doi: 10.1074/jbc.M202421200. Epub 2002 May 22. J Biol Chem. 2002. PMID: 12023962 Free article.

8

Endothelin-1 acts as a survival factor in ovarian carcinoma cells.

Del Bufalo D, Di Castro V, Biroccio A, Salani D, Rosanò L, Spinella F, Bagnato A. Del Bufalo D, et al. Among authors: rosano l. Clin Sci (Lond). 2002 Aug;103 Suppl 48:302S-305S. doi: 10.1042/CS103S302S. Clin Sci (Lond). 2002. PMID: 12193109

9

Endothelin-1 promotes proteolytic activity of ovarian carcinoma.

Rosanò L, Salani D, Di Castro V, Spinella F, Natali PG, Bagnato A. Rosanò L, et al. Clin Sci (Lond). 2002 Aug;103 Suppl 48:306S-309S. doi: 10.1042/CS103S306S. Clin Sci (Lond). 2002. PMID: 12193110

10

ABT-627, a potent endothelin receptor A antagonist, inhibits ovarian carcinoma growth in vitro.

Salani D, Rosanò L, Di Castro V, Spinella F, Venuti A, Padley RJ, Nicotra MR, Natali PG, Bagnato A. Salani D, et al. Among authors: rosano l. Clin Sci (Lond). 2002 Aug;103 Suppl 48:318S-321S. doi: 10.1042/CS103S318S. Clin Sci (Lond). 2002. PMID: 12193113

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page